MOH — authorised 13 July 1984
- Marketing authorisation holder: BRAINTREE
- Status: likely_approved
MOH authorised Miralax on 13 July 1984
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 13 July 1984.
BRAINTREE holds the UAE marketing authorisation.